RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion (vol 11, 665273, 2021) by He, Fang et al.
Frontiers in Oncology | www.frontiersin.org
Edited and reviewed by:
Xu Wang,






This article was submitted to
Molecular and
Cellular Oncology,
a section of the journal
Frontiers in Oncology
Received: 22 June 2021
Accepted: 28 June 2021
Published: 20 July 2021
Citation:
He F, Matsumoto Y, Asano Y,
Yamamura Y, Katsuyama T, Rose JL,
Tomonobu N, Komalasari NLGY,
Sakaguchi M, Rottapel R and
Wada J (2021) Corrigendum:
RUNX2 Phosphorylation by





published: 20 July 2021
doi: 10.3389/fonc.2021.729192Corrigendum: RUNX2
Phosphorylation by Tyrosine
Kinase ABL Promotes Breast
Cancer Invasion
Fang He1, Yoshinori Matsumoto1*, Yosuke Asano1, Yuriko Yamamura1,
Takayuki Katsuyama1, Jose La Rose2, Nahoko Tomonobu3, Ni Luh Gede Yoni Komalasari3,
Masakiyo Sakaguchi3, Masakiyo Sakaguchi3, Robert Rottapel2 and Jun Wada1
1 Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of
Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 2 Princess Margaret Cancer Center, University Health
Network, University of Toronto, Toronto, ON, Canada, 3 Department of Cell Biology, Okayama University Graduate School of
Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
Keywords: ABL—Abelson murine leukemia viral oncogene homolog, Runx2 (runt-related transcription factor 2),
tyrosine, phosphorylation, invasionA Corrigendum on
RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion
ByHe F,Matsumoto Y, Asano Y, Yamamura Y, Katsuyama T, Rose JL, Tomonobu N, Komalasari NLGY,
Sakaguchi M, Rottapel R and Wada J (2021). Front. Oncol. 11:665273. doi: 10.3389/fonc.2021.665273
In the original article, there was a mistake in Figures 1A, B, D, F, 2D, 3B–D, F, 4D, S5A as
published. We noticed that several qPCR data were not correctly normalized since the calculation
program of the DCt method did not work. The corrected Figures 1A, B, D, F, 2D, 3B–D, F, 4D,
S5A and the equivalent raw data in Figures S1–S4 and S5A appears below.
The authors apologize for these errors and state that this does not change the scientific
conclusions of the article in any way. The original article has been updated.July 2021 | Volume 11 | Article 7291921





FIGURE 1 | ABL kinase activity is required for RUNX2-mediated MMP13 expression. (A) Quantitative PCR analysis of MMP2, 9, and 13 mRNA expression in
HEK293T cells transfected with RUNX2. n = 3. (B) Quantitative PCR analysis of MMP13 mRNA expression in HEK293T cells co-transfected with RUNX2 with or
without TAZ or ABL (PP). n = 3. (C) HEK293T cells were co-transfected with RUNX2 with or without TAZ or ABL (PP). Whole cell lysates were probed with the
indicated antibodies for Western blot analysis. (D) Quantitative PCR analysis of MMP13 mRNA expression in HEK293T cells co-transfected with RUNX2 with or
without ABL (WT, PP or KD). n = 3. (E) HEK293T cells were co-transfected with RUNX2 with or without ABL (WT, PP or KD). Whole cell lysates were probed with
the indicated antibodies for Western blot analysis. (F) Quantitative PCR analysis of MMP13 mRNA expression in HEK293T cells co-transfected with RUNX2 with or
without ABL (PP) and cultured in the presence or absence of 10 mM imatinib for 24 hours. n = 3. P values were determined by the unpaired t-test (A) or ANOVA with
Tukey–Kramer’s post hoc test (B–F). Data are presented as means ± SEM. *P < 0.05.Frontiers in Oncology | www.frontiersin.org July 2021 | Volume 11 | Article 7291922




FIGURE 2 | ABL binds to, phosphorylates, and activates RUNX2 through its SH2 domain. (A–C) HEK293T cells were co-transfected with wild-type (WT) or all
tyrosine to phenylalanine mutant (YF) RUNX2 with or without ABL (PP). RUNX2 immune complexes were probed with an anti-phosphotyrosine (4G10), anti-
pY245ABL, anti-ABL or anti-RUNX2 antibody. Whole cell lysates (WCL) were probed with the indicated antibodies for Western blot analysis. (D) Quantitative PCR
analysis of MMP13 mRNA expression in HEK293T cells co-transfected with RUNX2 (WT or YF) with or without ABL (PP). n = 3. (E) HEK293T cells were co-
transfected with RUNX2 with or without GFP-ABL (SH2). GFP-ABL (SH2) immune complexes were probed with an anti-RUNX2 or anti-GFP antibody. P values were
determined by ANOVA with Tukey–Kramer’s post hoc test. Data are presented as means ± SEM. *P < 0.05.Frontiers in Oncology | www.frontiersin.org July 2021 | Volume 11 | Article 7291923





FIGURE 3 | RUNX2 transcriptional activity is dependent on the number of its tyrosine residues phosphorylated by ABL. (A) Schematic models of RUNX2 (WT) and
RUNX2 (YF). (B–D, F) Quantitative PCR analysis of MMP13 mRNA expression in HEK293T cells co-transfected with the indicated constructs. n = 3. (E) HEK293T
cells were co-transfected with the indicated constructs and RUNX2 immune complexes were probed with an anti-4G10 or anti-RUNX2 antibody. P values were
determined by ANOVA with Tukey–Kramer’s post hoc test. Data are presented as means ± SEM. *P < 0.05. ns, no significance.Frontiers in Oncology | www.frontiersin.org July 2021 | Volume 11 | Article 7291924
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FIGURE 4 | ABL regulates RUNX2 expression through control of the BMP-SMAD pathway. (A, B) Saos-2 cells were infected with an empty vector control or an
FKBP-ABL- or FKBP-expressing retroviral vector. Whole cell lysates were probed with the indicated antibodies for Western blot analysis. (C) Saos-2 cells were
infected with an empty vector control or an FKBP-ABL-expressing retroviral vector in the presence of shGFP or shBMPR1A. Whole cell lysates were probed with the
indicated antibodies for Western blot analysis. (D) Quantitative PCR analysis of MMP13 mRNA expression in cells in (C). n = 3. (E) MDA-MB231 cells were infected
with an shGFP-, shABL- or shRUNX2-expressing vector. Whole cell lysates were probed with the indicated antibodies for Western blot analysis. P values were
determined by ANOVA with Tukey–Kramer’s post hoc test. Data are presented as means ± SEM. *P < 0.05.Frontiers in Oncology | www.frontiersin.org July 2021 | Volume 11 | Article 7291925
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Supplementary Figure 1 | ABL kinase activity is required for RUNX2-mediated
MMP13 expression. (A–D) Independent raw data of the panels shown in Figures
1A (A), 1B (B), 1D (C) and 1F (D).
Supplementary Figure 2 | ABL binds to, phosphorylates, and activates RUNX2
through its SH2 domain. (A) Independent raw data of the panel shown in
Figure 2D.
Supplementary Figure 3 | RUNX2 transcriptional activity is dependent on the
number of its tyrosine residues phosphorylated by ABL. (A–D) Independent raw
data of the panels shown in Figures 3B (A), 3C (B), 3D (C) and 3F (D).
Supplementary Figure 4 | ABL regulates RUNX2 expression through control
of the BMP-SMAD pathway. (A) Independent raw data of the panel shown in
Figure 4D.Frontiers in Oncology | www.frontiersin.org 6Supplementary Figure 5 | ABL-mediated RUNX2 expression and
phosphorylation regulate breast cancer invasion. (A) Quantitative PCR analysis of
MMP13 mRNA expression in MDA-MB231 cells infected with an shGFP-, shABL-
or shRUNX2-expressing vector and the independent raw data. n = 3. (B) MDA-
MB231 cells infected with an shGFP-, shABL- or shRUNX2-expressing vector were
subjected to a Matrigel invasion assay, and invading cells in five independent
regions were counted. Representative photographs were taken at 10 ×
magnification. (C)MDA-MB231 cells stably expressing luciferase were infected with
an shGFP- or shABL-expressing vector and injected into the lateral tail veins of
BALB/c-nu/nu female mice as described in the methods section. After 4 weeks, the
presence of metastases was detected by IVIS, and regions of interest from
displayed images were identified and quantified as total photon counts or photons/
s. n = 6-7. (D) A representative image of H&E staining of the lungs from mice in (C).
P values were determined by the unpaired t-test (C) or ANOVA with Tukey–
Kramer’s post hoc test (A, B). Data are presented as means ± SEM. *P < 0.05.
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